In 2023, the U.S. government began a long-awaited process of negotiating prescription drug prices through the Medicare program, starting with a batch of 10 drugs picked from some of the most expensive.
Americans pay significantly more for prescription drugs on average than folks in many other high-income countries, and a recent report from the Commonwealth Fund identifies just how much — often double, triple or more. That’s even after the report took into account any rebates and discounts from full retail price available in the U.S. (resulting in net prices), while full retail prices were used for other countries.
Following is a comparison of American and foreign prices on the drugs for which Medicare is now negotiating with drug manufacturers.
Eliquis
Estimated U.S. net price: $4.11 per tablet
Highest retail price in comparison countries: $2.56 per tablet (Switzerland)
Lowest retail price in comparison countries: $1.16 per tablet (Australia)
Eliquis is made by Pfizer. It’s a blood thinner used to reduce the risk of stroke and blood clots. Medicare spent $12.6 billion on this drug in 2021.
Entresto
Estimated U.S. net price: $9.57 per tablet
Highest retail price in comparison countries: $4.51 per tablet (Switzerland)
Lowest retail price in comparison countries: $1.25 per tablet (Japan)
Entresto is designed to treat heart failure by fighting the buildup of sodium and preventing blood vessel tightening. It is made by Novartis.
Xarelto
Estimated U.S. net price: $7.87 per tablet
Highest retail price in comparison countries: $12 per tablet (Japan) — the only case in which the U.S. price was lower than another country’s
Lowest retail price in comparison countries: $1.99 per tablet (Australia)
Xarelto is used to reduce the risk of blood clots and strokes. It is made by Janssen. Medicare spent $5.2 billion on this drug in 2021.
Januvia
Estimated U.S. net price: $9.17 per tablet
Highest retail price in comparison countries: $3.33 per tablet (Canada)
Lowest retail price in comparison countries: 89 cents per tablet (Germany)
Januvia, which can cost as little as $5 per prescription through private insurance, helps manage blood sugar for type 2 diabetics. It is made by Merck.
Jardiance
Estimated U.S. net price: $10.15 per tablet
Highest retail price in comparison countries: $3.17 per tablet (Switzerland)
Lowest retail price in comparison countries: $1.45 per tablet (France)
Diabetes drug Jardiance is made by Eli Lilly and Boehringer Ingelheim. Medicare spent $3.7 billion on this drug in 2021 for about 885,000 people.
Farxiga
Estimated U.S. net price: $11.05 per tablet
Highest retail price in comparison countries: $3.05 per tablet (Switzerland)
Lowest retail price in comparison countries: $1.50 per tablet (Australia)
Known as Farxiga (pronounced “far-see-guh”) in the U.S. and Forxiga in Europe, this medication from AstraZeneca is used for conditions such as chronic kidney disease, heart failure and type 2 diabetes.
Novolog FlexPen
Estimated U.S. net price: $19.86 per milliliter
Highest retail price in comparison countries: $5.36 per milliliter (Switzerland)
Lowest retail price in comparison countries: $2.26 per milliliter (Australia)
NovoLog is one of many insulin injection pens on the market, and comes in a dozen different color patterns. It is made by Novo Nordisk and used to treat diabetes.
Imbruvica
Estimated U.S. net price: $436.54 per pill
Highest retail price in comparison countries: $325.91 per pill (Switzerland)
Lowest retail price in comparison countries: $89.68 per pill (Australia)
Imbruvica is a cancer treatment drug made by Pharmacyclics and Janssen, pharmaceutical companies owned by AbbVie and Johnson & Johnson, respectively. Medicare spent $3.2 billion on this drug in 2021.
Enbrel
Estimated U.S. net price: $1,202.17 per milliliter
Highest retail price in comparison countries: $455.92 per milliliter (Switzerland)
Lowest retail price in comparison countries: $133.62 per milliliter (Japan)
Enbrel is a treatment for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and plaque psoriasis. It is marketed by Amgen.
Stelara
Estimated U.S. net price: $12,946.15 per milliliter
Highest retail price in comparison countries: $9,223.14 per milliliter (Germany)
Lowest retail price in comparison countries: $2,430.60 per milliliter (Australia)
Stelara is used to treat Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. It is marketed by Janssen Biotech.
Get smarter with your money!
Want the best money-news and tips to help you make more and spend less? Then sign up for the free Money Talks Newsletter to receive daily updates of personal finance news and advice, delivered straight to your inbox. Sign up for our free newsletter today.